ELVN
NASDAQ · Pharmaceuticals
Enliven Therapeutics Inc
$49.28
+4.49 (+10.02%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
-35.7% upside
Low Target
$20.91
Average Target
$31.67
High Target
$36.06
Current Price
$49.28
Current
$49.28
$49.28
Target
$31.67
$31.67
$20.91
$31.67 avg
$36.06
Scenario Analysis
Bear Case
$20.91
-57.6%
Low target
Base Case
$31.67
-35.7%
Avg target
Bull Case
$36.06
+-26.8%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$62.32
-20.9% from high
52-Week Low
$14.79
+233.3% from low
Target vs 52W High
$31.67
-49.2% vs high
Next Earnings Report
Nov 18, 2026
10d
until earnings
EPS Est: $-0.46
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals